Repeated botulinum toxin type A (Dysport®) injections for women with intractable detrusor overactivity: a prospective outcome study
作者： Lanka Abeywickrama , Angamuthu Arunkalaivanan , Monica Quinlan
DOI: 10.1007/S00192-013-2228-2
关键词:
摘要: Introduction and hypothesis We present the cohort of 33 women who underwent botulinum toxin type A (BTX-A) injections examining efficacy safety BTX-A in idiopathic detrusor overactivity (IDO). The aim this report is to describe outcomes those repeated BTX-A.
springer.com
sci-hub.se 参考文章(20)
André Santos-Silva, Carlos Martins da Silva, Francisco Cruz, Botulinum toxin treatment for bladder dysfunction International Journal of Urology. ,vol. 20, pp. 956- 962 ,(2013) , 10.1111/IJU.12188
A. K. PATEL, J. M. PATTERSON, C. R. CHAPPLE, The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity International journal of clinical practice. Supplement. ,vol. 60, pp. 27- 32 ,(2006) , 10.1111/J.1742-1241.2006.01212.X
Amar Mohee, Ayisha Khan, Neil Harris, Ian Eardley, Long‐term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB) BJUI. ,vol. 111, pp. 106- 113 ,(2013) , 10.1111/J.1464-410X.2012.11282.X
Pravisha Ravindra, Benjamin L. Jackson, Richard J. Parkinson, Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox®) or abobotulinumtoxinA (Dysport®) make a difference? BJU International. ,vol. 112, pp. 94- 99 ,(2013) , 10.1111/BJU.12028
Prokar Dasgupta, Volume matters: bladder injections of botulinum toxin type A. European Urology. ,vol. 61, pp. 1185- 1186 ,(2012) , 10.1016/J.EURURO.2012.02.043
Roberta Granese, Giorgio Adile, Giorgio Gugliotta, Gaspare Cucinella, Salvatore Saitta, Biagio Adile, Botox® for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection Archives of Gynecology and Obstetrics. ,vol. 286, pp. 923- 929 ,(2012) , 10.1007/S00404-012-2349-8
Arun Sahai, Philippa Sangster, Vinay Kalsi, Mohammad S Khan, Clare J Fowler, Prokar Dasgupta, None, Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable? BJU International. ,vol. 103, pp. 630- 634 ,(2009) , 10.1111/J.1464-410X.2008.08076.X
Arun Sahai, Christopher Dowson, Mohammad S Khan, Prokar Dasgupta, None, Improvement in quality of life after botulinum toxin‐A injections for idiopathic detrusor overactivity: results from a randomized double‐blind placebo‐controlled trial BJUI. ,vol. 103, pp. 1509- 1515 ,(2009) , 10.1111/J.1464-410X.2009.08402.X
Brigitte Schurch, Daniel M. Schmid, Manfred Stöhrer, Treatment of Neurogenic Incontinence with Botulinum Toxin A New England Journal of Medicine. ,vol. 342, pp. 665- 665 ,(2000) , 10.1056/NEJM200003023420918
Delphine Behr-Roussel, Stephanie Oger, Bernadette Pignol, Emmanuel Pham, Amélie Le Maux, Pierre-Etienne Chabrier, Stephanie Caisey, Sandrine Compagnie, Philippe Picaut, Jacques Bernabé, Laurent Alexandre, François Giuliano, Pierre Denys, None, Minimal Effective Dose of Dysport and Botox in a Rat Model of Neurogenic Detrusor Overactivity European Urology. ,vol. 61, pp. 1054- 1061 ,(2012) , 10.1016/J.EURURO.2012.01.051